(ANIX) is set to present final Phase 1 clinical trial results for its breast cancer vaccine at the 2025 San Antonio Breast Cancer Symposium (SABCS) on ...
News
- Is Anixa's First-In-Human Vaccine Poised For Regulatory Momentum? - RTTNews
- G&A Partners Acquires San Antonio-Based PEOs Integrity HRM and Covenant Services
Allen. “These two acquisitions will expand our presence in the San Antonio market and allow us to provide small and medium businesses there with even ...
- bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct ... - Nasdaq
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive ...
- bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing ...
SAN ANTONIO--(BUSINESS WIRE)--Oct 9, 2025--. bioAffinity Technologies, Inc.(NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for ...
- Making sense of the 'senseless' after a breakthrough in Austin's yogurt shop murder case
Bioscience-Medicine · Border & Immigration · Economy & Labor · Criminal ... San Antonio City Hall and other downtown buildings usually lit up to ...